Dexcom anticipates that the findings could drive a shift in the standard of care for type 2 diabetes patients who do not use ...

Medical device maker Dexcom said the use of its continuous glucose monitor, G7, led to improved blood sugar control in ...

DexCom, Inc. (NASDAQ:DXCM) announced today results from the CONNECT randomized controlled trial, demonstrating the use of ...

DexCom, Inc. DXCM recently announced positive results from its CONNECT randomized controlled trial, demonstrating that use of ...

DexCom Inc. DXCM stock is trading higher on Monday after the diabetes management company reported positive results from its ...

～高精度で小型化、起動時間を短縮し、使いやすさの向上を目指したデバイス～ デクスコムジャパン合同会社（本社：東京都目黒区、日本法人社長 浅野 元）は本日、リアルタイムCGM「Dexcom G7 ...

Researchers shared findings today at the American Diabetes Association Scientific Sessions (ADA 2026) in New Orleans. San ...

A new study presented at the American Diabetes Association found that Dexcom’s G7 continuous glucose monitor significantly ...

Customers have known for months that the Dexcom G7 continuous glucose monitoring sensor had problems. Now, the company is ...

The diabetes tech firm has identified two lots of G7 sensors that have been stolen, sold and used by customers.

Dexcom says stolen G7 sensors from two scrapped lots were sold through unauthorized channels, creating infection and reading-failure risks.

Dexcom (Nasdaq:DXCM) announced today that third parties stole and sold certain G7 continuous glucose monitor (CGM) lots ...